Journal of the Egyptian Veterinary Medical Association · 1980 · 13 citations · 5 references
Life SciencesInfectious DiseasesMicrobiologyEgyptologyMedical MicrobiologyMycologyMast Cell ActivationMast Cell DisordersMastitisMastitis DiagnosisMastitis DiagnosticsMastitis-associated Microorganisms
Phospholipase D preferentially contained in human eosinophil polymorphonuclear leukocytes as compared to other leukocytes was isolated by sequential asion and cation exchange chromatography and gel filtration. The purified eosinophil enzyme specifically liberated choline from I-alpha-phosphatidyl choline with a pH optimum of 4.5-6.0 and exhibited a pI of 5.8-6.2 on polyacrylamide-gel isoelectric focusing, which are properties shared by phospholipase D from plant sources; however, its apparent mol wt of 60,000 is approximately one-half that of the plant enzymes. Eosinophil and cabbage phospholipase D inactivated a partially purified rat platelet-activating factor (PAF) in a time- and dose-dependent reaction. The cleavage of this PAF activity was attributed to the inherent phospholipase D activity of the eosinophil enzyme since the two activities chromatographed together at each purification step, and there was apparent reciprocal inhibition of choline-generating activity by PAF and of PAF-inactivating activity by phosphatidyl choline. Thus, possible regulatory functions of the eosinophil in immediate hypersensitivity reactions include inactivation of a PAF by phospholipase D as well as degradation of slow-reacting substance of anaphylaxis by arylsulfatase B.
5
The physicochemical characteristics and purification of slow-reacting substance of anaphylaxis.
Orange Rp, Murphy Rc, Karnovsky Ml et al. · PubMed · 1973 · 169 citations
The release of four mediators of immediate hypersensitivity from human leukemic basophils.
Lewis Ra, Goetzl Ej, Wasserman Si et al. · PubMed · 1975 · 114 citations